Does Dr. MONA GRAHAM ALEXANDER have financial conflicts of interest?

Dr. MONA GRAHAM ALEXANDER (FNP-BC, CNOR, RNFA) has received a total of $256 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $256 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MONA GRAHAM ALEXANDER?

According to CMS Open Payments data, Dr. MONA GRAHAM ALEXANDER received funding from AXSOME THERAPEUTICS ($122), ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .) ($119), and ALKERMES ($15).

Does Dr. MONA GRAHAM ALEXANDER receive research grants or speaking fees?

Dr. MONA GRAHAM ALEXANDER has received $256 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MONA GRAHAM ALEXANDER

FNP-BC, CNOR, RNFAReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: HATTIESBURG, MS 39402

NPI Number: 1053496489

LIFETIME INDUSTRY VALUE

$256

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GRAHAM ALEXANDER is a verified Nurse Practitioner, Family practitioner based in HATTIESBURG, MS.

Between 2021 and 2025, Dr. GRAHAM ALEXANDER had an overall industry promotional and research financial footprint of $256 as recorded in the federal CMS Open Payments database.

$256 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GRAHAM ALEXANDER's primary funding source is AXSOME THERAPEUTICS, which accounts for $122 (representing 47.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AXSOME THERAPEUTICS

Rank 1

$122

47.6%

ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .)

Rank 2

$119

46.4%

ALKERMES

Rank 3

$15

5.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.